Previous studies have shown that RTL1 is involved in several cancers, including lung cancer [12], squamous cell carcinoma of head and neck [13], and hepatocellular carcinoma [14–15], and the methylation level of RTL1 in melanoma patients is significantly lower than people without cancer [33]. Here, RTL1 is linked to melanoma.